Chronic Gastritis in Dermatitis Herpetiformis: A Controlled Study
Table 2
Gastric and duodenal findings, dapsone, and gluten-free diet (GFD) treatment, and associated diseases and malignancies in 16 dermatitis herpetiformis (DH) patients with chronic atrophic gastritis.
Patient no.
Sex/age (years)
Year of DH diagnosis
Gastric findings
Duodenal histology at diagnosis/on GFD
Associated autoimmune diseases and malignancies
Corpus atrophy/metaplasia1
Antrum atrophy/metaplasia1
Helicobacter pylori
1
F/53
1996
1/1
0/0
−
PVA
Breast cancer 1992
2
F/69
1999
1/0
0/0
−
PVA
—
3
M/68
2000
1/2
2/2
−
PVA/N
Gastric cancer 2001
4
M/64
2001
3/2
0/0
−
PVA/N
Hypothyreosis >10 yrs before DH diagnosis Prostate cancer 2010
5
M/61
2001
1/0
0/1
−
N/N
—
6
F/58
2001
1/0
0/0
+
PVA/N
—
7
F/62
2001
2/0
0/0
−
PVA
Breast cancer 1992
8
M/57
2001
1/0
0/0
+
PVA
—
9
M/48
2002
1/0
0/0
+
N
—
10
M/71
2003
2/1
0/0
−
N
Vitiligo 2003
11
F/56
2003
3/1
0/0
−
PVA/N
Pernicious anemia 2004 Graves’ disease 2005
12
M/71
2004
2/1
0/2
+
N
—
13
M/76
2006
3/2
0/1
−
N
—
14
F/74
2007
1/0
1/0
+
PVA
—
15
F/63
2007
1/0
0/0
+
SVA
—
16
M/69
2008
0/0
+
SVA
—
SVA: subtotal villous atrophy, PVA: partial villous atrophy, N: normal mucosa at diagnosis and on a gluten-free diet (GFD). 1score 0–3 according to the Sydney System.